TY - JOUR
T1 - Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses
AU - Chatterjee, Srirupa
AU - Luthra, Priya
AU - Esaulova, Ekaterina
AU - Agapov, Eugene
AU - Yen, Benjamin C.
AU - Borek, Dominika M.
AU - Edwards, Megan R.
AU - Mittal, Anuradha
AU - Jordan, David S.
AU - Ramanan, Parameshwar
AU - Moore, Martin L.
AU - Pappu, Rohit V.
AU - Holtzman, Michael J.
AU - Artyomov, Maxim N.
AU - Basler, Christopher F.
AU - Amarasinghe, Gaya K.
AU - Leung, Daisy W.
N1 - Publisher Copyright:
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
PY - 2017/6/30
Y1 - 2017/6/30
N2 - Human respiratory syncytial virus (hRSV) is a major cause of morbidity and mortality in the paediatric, elderly and immune-compromised populations 1,2. A gap in our understanding of hRSV disease pathology is the interplay between virally encoded immune antagonists and host components that limit hRSV replication. hRSV encodes for non-structural (NS) proteins that are important immune antagonists 3-6; however, the role of these proteins in viral pathogenesis is incompletely understood. Here, we report the crystal structure of hRSV NS1 protein, which suggests that NS1 is a structural paralogue of hRSV matrix (M) protein. Comparative analysis of the shared structural fold with M revealed regions unique to NS1. Studies on NS1 wild type or mutant alone or in recombinant RSVs demonstrate that structural regions unique to NS1 contribute to modulation of host responses, including inhibition of type I interferon responses, suppression of dendritic cell maturation and promotion of inflammatory responses. Transcriptional profiles of A549 cells infected with recombinant RSVs show significant differences in multiple host pathways, suggesting that NS1 may have a greater role in regulating host responses than previously appreciated. These results provide a framework to target NS1 for therapeutic development to limit hRSV-associated morbidity and mortality.
AB - Human respiratory syncytial virus (hRSV) is a major cause of morbidity and mortality in the paediatric, elderly and immune-compromised populations 1,2. A gap in our understanding of hRSV disease pathology is the interplay between virally encoded immune antagonists and host components that limit hRSV replication. hRSV encodes for non-structural (NS) proteins that are important immune antagonists 3-6; however, the role of these proteins in viral pathogenesis is incompletely understood. Here, we report the crystal structure of hRSV NS1 protein, which suggests that NS1 is a structural paralogue of hRSV matrix (M) protein. Comparative analysis of the shared structural fold with M revealed regions unique to NS1. Studies on NS1 wild type or mutant alone or in recombinant RSVs demonstrate that structural regions unique to NS1 contribute to modulation of host responses, including inhibition of type I interferon responses, suppression of dendritic cell maturation and promotion of inflammatory responses. Transcriptional profiles of A549 cells infected with recombinant RSVs show significant differences in multiple host pathways, suggesting that NS1 may have a greater role in regulating host responses than previously appreciated. These results provide a framework to target NS1 for therapeutic development to limit hRSV-associated morbidity and mortality.
UR - http://www.scopus.com/inward/record.url?scp=85021674585&partnerID=8YFLogxK
U2 - 10.1038/nmicrobiol.2017.101
DO - 10.1038/nmicrobiol.2017.101
M3 - Article
C2 - 28665409
AN - SCOPUS:85021674585
SN - 2058-5276
VL - 2
JO - Nature microbiology
JF - Nature microbiology
M1 - 17101
ER -